NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report

Xiao-Dan YAN, Yan-Yan CHEN, Li TAO

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (5) : 609-612.

PDF(720 KB)
HTML
PDF(720 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (5) : 609-612. DOI: 10.7499/j.issn.1008-8830.2411150
CASE REPORT

NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report

Author information +
History +

Abstract

A male neonate was admitted on postnatal day 1 with persistent pulmonary hypertension. Despite aggressive treatment, the pulmonary hypertension progressively worsened, leading to early right heart failure. Whole-exome sequencing of the family revealed compound heterozygous mutations c.192del and c.192_193del in the NDUFAF2 gene, inherited from each parent, meeting the pathogenic variant criteria of the American College of Medical Genetics and Genomics. Autopsy showed pulmonary artery dilation and myocardial hypertrophy, with no evidence of alveolar capillary dysplasia on lung tissue electron microscopy. Mutations in the NDUFAF2 gene are associated with mitochondrial complex I deficiency. This is the first reported case associating NDUFAF2 mutations with neonatal primary pulmonary hypertension, providing new genetic evidence for this condition and highlighting the importance of genetic and pathological studies in severe neonatal diseases.

Key words

Primary pulmonary hypertension / NDUFAF2 gene / Neonate

Cite this article

Download Citations
Xiao-Dan YAN , Yan-Yan CHEN , Li TAO. NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(5): 609-612 https://doi.org/10.7499/j.issn.1008-8830.2411150

References

1
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30 .
2
Mukherjee D, Konduri GG. Pediatric pulmonary hypertension: definitions, mechanisms, diagnosis, and treatment[J]. Compr Physiol, 2021, 11(3): 2135-2190. PMCID: PMC8289457. DOI: 10.1002/cphy.c200023 .
3
Grady RM, Eghtesady P. Potts shunt and pediatric pulmonary hypertension: what we have learned[J]. Ann Thorac Surg, 2016, 101(4): 1539-1543. DOI: 10.1016/j.athoracsur.2015.08.068 .
4
Latus H, Apitz C, Moysich A, et al. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies[J]. J Heart Lung Transplant, 2014, 33(5): 542-546. DOI: 10.1016/j.healun.2014.01.860 .
5
Lancaster TS, Shahanavaz S, Balzer DT, et al. Midterm outcomes of the Potts shunt for pediatric pulmonary hypertension, with comparison to lung transplant[J]. J Thorac Cardiovasc Surg, 2021, 161(3): 1139-1148. DOI: 10.1016/j.jtcvs.2020.10.163 .
6
Hayes D, Jennerich AL, Coleman RD, et al. Interventional strategies for children with progressive pulmonary hypertension despite optimal therapy: an official American Thoracic Society clinical practice guideline[J]. Am J Respir Crit Care Med, 2025, 211(2): 157-173. PMCID: PMC11812548. DOI: 10.1164/rccm.202410-1901ST .
7
Singh Y, Lakshminrusimha S. Pathophysiology and management of persistent pulmonary hypertension of the newborn[J]. Clin Perinatol, 2021, 48(3): 595-618. PMCID: PMC8351908. DOI: 10.1016/j.clp.2021.05.009 .
8
Lambert M, Mendes-Ferreira P, Ghigna MR, et al. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload[J]. Cardiovasc Res, 2021, 117(12): 2474-2488. DOI: 10.1093/cvr/cvab016 .
9
Haarman MG, Kerstjens-Frederikse WS, Vissia-Kazemier TR, et al. The genetic epidemiology of pediatric pulmonary arterial hypertension[J]. J Pediatr, 2020, 225: 65-73.e5. DOI: 10.1016/j.jpeds.2020.05.051 .
10
Herzer M, Koch J, Prokisch H, et al. Leigh disease with brainstem involvement in complex I deficiency due to assembly factor NDUFAF2 defect[J]. Neuropediatrics, 2010, 41(1): 30-34. DOI: 10.1055/s-0030-1255062 .
11
Schlehe JS, Journel MS, Taylor KP, et al. The mitochondrial disease associated protein Ndufaf2 is dispensable for Complex-1 assembly but critical for the regulation of oxidative stress[J]. Neurobiol Dis, 2013, 58: 57-67. PMCID: PMC3748239. DOI: 10.1016/j.nbd.2013.05.007 .
12
Gallo G, Forte M, Cotugno M, et al. Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension[J]. Mol Med, 2023, 29(1): 107. PMCID: PMC10410816. DOI: 10.1186/s10020-023-00701-x .
13
MacMAHON HE. Congenital alveolar dysplasia; a developmental anomaly involving pulmonary alveoli[J]. Pediatrics, 1948, 2(1): 43-57.
14
Chan CD, Niyogi A, Jaffray B, et al. Lung biopsy in children: when is it useful?[J]. Arch Dis Child, 2021, 106(3): 291-293. DOI: 10.1136/archdischild-2019-318443 .
15
Swinton CH, Weiner J, Okah FA. The neonatal autopsy: can it be revived?[J]. Am J Perinatol, 2013, 30(9): 739-744. DOI: 10.1055/s-0032-1332798 .

颜晓丹负责文章设计、撰写及病例收集;陈艳艳和陶莉负责病例筛选和审核。

PDF(720 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/